U.S. fines American Airlines, Delta for long tarmac delays
February 28, 2019HBO Chief Executive Richard Plepler to resign from company
February 28, 2019Starboard joins opposition to Bristol-Myers’ $74 billion Celgene deal
at
Activist hedge fund Starboard Value LP followed Bristol-Myers Squibb Co’s second-largest investor, Wellington Management, in opposing the drugmaker’s $74 billion purchase of biotech Celgene Corp on Thursday, sowing further doubt on would be the largest pharmaceutical acquisition of all time.
Powered by WPeMatico
